Rounding behavior in the reporting of headache frequency complicates headache chronification research

Headache

Volumn 53, Issue 6, 2013, Pages 908-919

  Houle, Timothy T ^a   Turner, Dana P ^a   Houle, Thomas A ^b   Smitherman, Todd A ^c   Martin, Vincent ^d   Penzien, Donald B ^e   Lipton, Richard B ^f  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Houle Psychology Clinic   (United States)

^c UNIVERSITY OF MISSISSIPPI   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

headache chronification; headache frequency; rounding; statistics

Indexed keywords

ARTICLE; BINOMIAL DISTRIBUTION; DEPRESSION; EPISODIC MIGRAINE; EPISODIC TENSION HEADACHE; FEMALE; HEADACHE; HUMAN; INCIDENCE; MALE; MEASUREMENT ERROR; POPULATION DISTRIBUTION; PRIORITY JOURNAL; REMISSION; SECONDARY ANALYSIS; TRANSFORMED MIGRAINE;

ADULT; BIOMEDICAL RESEARCH; DATA COLLECTION; FEMALE; FOLLOW-UP STUDIES; HEADACHE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PAIN MEASUREMENT; POPULATION SURVEILLANCE; PREVALENCE; UNITED STATES;

EID: 84878503256     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/head.12126     Document Type: Article

References (19)

1. Stewart WF, Wood C, Reed ML, Roy J, Lipton RB,; AMPP Advisory Group. Cumulative lifetime migraine incidence in women and men. Cephalalgia. 2008; 28: 1170-1178.
2. International Headache Society. The International Classification of Headache Disorders, 2nd edition. Cephalalgia. 2004; 24 (Suppl. 1): 1-160.
3. Tfelt-Hansen P, Pascual J, Ramadan N, et al. International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators. Cephalalgia. 2012; 32: 6-38.
4. Turner DP, Smitherman TA, Penzien DB, Lipton RB, Houle TT,. Rethinking headache chronification. Headache. 2013 (forthcoming).
5. Stewart WF, Lipton RB, Kolodner KB, Sawyer J, Lee C, Liberman JN,. Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain. 2000; 88: 41-52.
6. Hahn SR, Lipton RB, Sheftell FD, et al. Healthcare provider-patient communication and migraine assessment: Results of the American Migraine Communication Study, phase II. Curr Med Res Opin. 2008; 24: 1711-1718.
7. Lipton RB, Hahn SR, Cady RK, et al. In-office discussions of migraine: Results from the American Migraine Communication Study. J Gen Intern Med. 2008; 23: 1145-1151.
8. Heitjan DF, Rubin DB,. Inference from coarse data via multiple imputation with application to age heaping. J Am Stat Assoc. 1990; 85: 304-314.
9. Wang H, Heitjan DF,. Modeling heaping in self-reported cigarette counts. Stat Med. 2008; 27: 3789-3804.
10. Buse DC, Manack A, Serrano D, Turkel C, Lipton RB,. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010; 81: 428-432.
11. Munakata J, Hazard E, Serrano D, et al. Economic burden of transformed migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache. 2009; 49: 498-508.
12. Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB,. Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study. Headache. 2008; 48: 1157-1168.
13. Bigal ME, Ashina S, Burstein R, et al.; AMPP Group. Prevalence and characteristics of allodynia in headache sufferers: A population study. Neurology. 2008; 70: 1525-1533.
14. Bigal ME, Lipton RB, Winner P, Reed ML, Diamond S, Stewart WF,; AMPP Advisory Group. Migraine in adolescents: Association with socioeconomic status and family history. Neurology. 2007; 69: 16-25.
15. Silberstein S, Loder E, Diamond S, Reed ML, Bigal ME, Lipton RB,; AMPP Advisory Group. Probable migraine in the United States: Results of the American Migraine Prevalence and Prevention (AMPP) study. Cephalalgia. 2007; 27: 220-234.
16. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF,; AMPP Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007; 68: 343-349.
17. Stewart WF, Lipton RB, Dowson AJ, Sawyer J,. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability (Review). Neurology. 2001; 56 (6 Suppl. 1): S20-S28.
18. Kroenke K, Spitzer RL, Williams JB,. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med. 2001; 16: 606-613.
19. Dodick DW, Turkel CC, DeGryse RE, et al. OnabotulinumtoxinA for treatment of chronic migraine: Pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache. 2010; 50: 921-936.